Of the three CXCR2 ligands, CXCL5 is the most highly expressed in primary tumors (Figure 1E) and is therefore likely to be the major mediator of the preferential recruitment of PMN-MDSC to the primary tumor. The gene discussed is CXCR2; the disease is neoplasm.